What is IDEXX Laboratories's expected EPS for Q2 2026?

Analysts expect IDEXX Laboratories (IDXX) to report consensus EPS of approximately $3.93 for Q2 2026. Estimates range from $3.81 to $4.03.

What revenue do analysts expect for IDEXX Laboratories in Q2 2026?

The consensus revenue forecast for IDEXX Laboratories (IDXX) in Q2 2026 is approximately $1.2B. Forecasts range from $1.19B to $1.21B.

How many analysts cover IDEXX Laboratories?

9 analysts contribute to the IDEXX Laboratories (IDXX) Q2 2026 consensus estimate.

Has IDEXX Laboratories beaten earnings estimates recently?

IDEXX Laboratories beat analyst EPS estimates in 1 of the last 1 quarter. IDEXX Laboratories beat revenue estimates in 1 of 1. In the most recent quarter (Q1 2026), IDEXX Laboratories EPS beat by 1.8% and revenue beat by 2%.

When does IDEXX Laboratories report Q2 2026 earnings?

IDEXX Laboratories (IDXX) is expected to report Q2 2026 earnings on August 4, 2026 before market open.

IDXX Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$3.93

Consensus revenue · Q2 2026

$1.2B

Analysts

Expected report

Aug 4, 2026

Before open

Upcoming earnings

Locks in 11 days 13 hours · BMO: Locks 8:00 PM ET previous day

Revenue$1.2B$1.2B – $1.2B

EPS$3.93$3.81 – $4.03

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 9 analysts.

Metric	Low	Consensus	High
Revenue	$1.2B	$1.2B	$1.2B
EPS	$3.81	$3.93	$4.03
EBITDA	$386.9M	$390.1M	$393.4M
EBIT	$349.9M	$352.9M	$355.8M
Net income	$307.3M	$318.6M	$325M

Revenue$1.2B
EPS$3.93
EBITDA$390.1M
EBIT$352.9M
Net income$318.6M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q1 2026	$1.1B	$1.1B	+2.0%	$3.47	$3.41	+1.8%

Q1 2026+2.0%+1.8%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for IDEXX Laboratories (IDXX) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 0 analysts.

Low: $640.00
Consensus: $747.50
Median: $775.00
High: $800.00
Current: $545.00
Upside: +37.2%

Upside calculated vs most recent trading price of $545.00.

Analyst ratings

Consensus: Buy — based on 22 analyst ratings.

Buy 13Hold 8Sell 1

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Apr 28, 2026	UBS	maintain	Neutral	Neutral
Mar 31, 2026	Stifel	maintain	Buy	Buy
Feb 9, 2026	Piper Sandler	maintain	Neutral	Neutral
Feb 5, 2026	Barclays	maintain	Overweight	Overweight
Feb 3, 2026	UBS	maintain	Neutral	Neutral
Feb 3, 2026	BTIG	maintain	Buy	Buy
Nov 4, 2025	UBS	maintain	Neutral	Neutral
Nov 4, 2025	Morgan Stanley	maintain	Overweight	Overweight
Nov 4, 2025	JP Morgan	maintain	Overweight	Overweight
Nov 4, 2025	BTIG	maintain	Buy	Buy

Apr 28, 2026UBSNeutral
Mar 31, 2026StifelBuy
Feb 9, 2026Piper SandlerNeutral
Feb 5, 2026BarclaysOverweight
Feb 3, 2026UBSNeutral
Feb 3, 2026BTIGBuy
Nov 4, 2025UBSNeutral
Nov 4, 2025Morgan StanleyOverweight
Nov 4, 2025JP MorganOverweight
Nov 4, 2025BTIGBuy

Frequently asked questions

IDEXX Laboratories (IDXX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

IDXX Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation